These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 2225880

  • 21. Risk factors for macrovascular disease in type 2 diabetes. Classic lipid abnormalities.
    Steiner G.
    Diabetes Care; 1999 Apr; 22 Suppl 3():C6-9. PubMed ID: 10189556
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Evaluation of selected risk factors of atherosclerosis in children with type 1 diabetes mellitus and hypercholesterolemia].
    Muchacka-Bianga M, Deja G, Jarosz-Chobot P, Małecka-Tendera E, Kalina M, Grychtoł M.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Apr; 12(1):25-30. PubMed ID: 16704858
    [Abstract] [Full Text] [Related]

  • 26. [Longitudinal studies on the prognostic significance of plasma fibrinogen in diabetes mellitus].
    Schmechel H, Beiküfner P, Panzram G.
    Z Gesamte Inn Med; 1984 Sep 15; 39(18):453-7. PubMed ID: 6506821
    [Abstract] [Full Text] [Related]

  • 27. Apolipoprotein B level in patients with type 2 diabetes who achieved goal of low density lipoprotein cholesterol and non-high density lipoprotein cholesterol.
    Sathavarodom N, Boonyavarakul A.
    J Med Assoc Thai; 2010 Nov 15; 93 Suppl 6():S166-72. PubMed ID: 21280530
    [Abstract] [Full Text] [Related]

  • 28. [Features of Japanese diabetic macroangiopathy].
    Kaneko M, Furukawa K, Sone H.
    Nihon Rinsho; 2016 Apr 15; 74 Suppl 2():22-6. PubMed ID: 27266057
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Decrease of serum ascorbic acid concentrations in patients with diabetic macroangiopathy.
    Nagano S, Kurokawa M, Ebara T, Naito H, Sakamaki R, Furukawa S, Hirano T, Maeda M, Tsuji A.
    J Nutr Sci Vitaminol (Tokyo); 1996 Feb 15; 42(1):1-9. PubMed ID: 8708816
    [Abstract] [Full Text] [Related]

  • 34. Serum lipids and apolipoproteins and their relationship with macrovascular disease in type 1 diabetes.
    Merrin PK, Renton S, Fisher C, Henderson A, Richmond W, Nicholaides A, Elkeles RS.
    Diabet Med; 1994 May 15; 11(4):402-6. PubMed ID: 8088114
    [Abstract] [Full Text] [Related]

  • 35. Insulin-like growth factor-I in type 2 (non-insulin-dependent) diabetics with myocardial infarction and without macroangiopathy.
    Järveläinen H, Rönnemaa T, Kallio V.
    Atherosclerosis; 1986 Mar 15; 59(3):335-40. PubMed ID: 3964354
    [Abstract] [Full Text] [Related]

  • 36. [Comparison of the diagnostic contribution of rheography and ultrasound in diabetic macroangiopathy of the lower extremities].
    Lacko A, Kreze A, Hanzen E.
    Vnitr Lek; 1991 Mar 15; 37(7-8):665-70. PubMed ID: 1755207
    [Abstract] [Full Text] [Related]

  • 37. Diabetic macroangiopathy. Medial calcifications, narrowing, rugosities, stiffness, norepinephrine depletion and reduced blood flow capacity in the leg arteries.
    Neubauer B, Christensen NJ, Christensen T, Gundersen HJ, Jørgensen J.
    Acta Med Scand Suppl; 1984 Mar 15; 687():37-45. PubMed ID: 6591757
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Topographic distribution of peripheral arteriopathy in non-diabetics and type 2 diabetics.
    Lanzer P.
    Z Kardiol; 2001 Feb 15; 90(2):99-103. PubMed ID: 11263009
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.